Jardiance
JARDIANCE is a type 2 diabetes medication which was later found to significantly reduce the risk of cardiovascular death in adults. Evoke was tapped to launch the new heart failure indication with the unique challenge of having to use the existing JARDIANCE branding in a way that felt fresh. This was done by taking the "bugle" icon and transforming it into a heart which was used across a wide range of digital and print collateral. The result is a visual language that has a clear connection to the original branding but is unique and avoids confusion.